We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current OSSFF market cap is 1.83B. The company's latest EPS is USD 0.1365 and P/E is 31.28.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 686.26M | 629.5M | 718.67M | 718.65M | 785.68M |
| Operating Income | 97.98M | 28.58M | 97.71M | 65.2M | 92.79M |
| Net Income | 66.04M | 6.21M | 63.99M | 42.51M | 58.39M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.09B | 1.21B | 1.25B | 1.33B | 1.39B |
| Total Liabilities | 521.72M | 637.14M | 620.32M | 689.85M | 680.68M |
| Total Equity | 568.96M | 577.19M | 626.6M | 635.51M | 705.01M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 95.28M | 92.24M | 100.53M | 60.77M | 94.32M |
| Investing | -62.36M | -106.45M | -59.45M | -66.26M | -57.15M |
| Financing | -29.3M | 51.86M | -51.07M | 3.79M | -40.96M |
| Market Cap | 1.83B |
| Price to Earnings Ratio | 31.28 |
| Price to Sales Ratio | 2.32 |
| Price to Cash Ratio | 25.13 |
| Price to Book Ratio | 2.59 |
| Dividend Yield | - |
| Shares Outstanding | 427.64M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 1.3k |
| 52 Week Change | -10.11% |
| 52 Week High | 4.97 |
| 52 Week Low | 3.63 |
| Spread (Intraday) | 0.45 (10.25%) |
| Company Name | Embla Medical (PK) |
| Address |
grjothals 1-5 reykjavik 110 |
| Website | https://www.emblamedical.com |
| Industry | medical instruments & machines (A83) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
